Sarepta Therapeutics (SRPT) Shares Outstanding (2010 - 2026)

Sarepta Therapeutics has reported Shares Outstanding for 17 years, with the latest figure at $106227.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 8.11% year-over-year to $106227.0; the trailing twelve-month figure through Mar 2026 stood at $106227.0 (up 8.11% YoY), and the FY2025 full-year result was $105.0 million, up 108222.21% from the prior year.
• Shares Outstanding for Q1 2026 stood at $106227.0, down from $105.0 million in the prior quarter.
• The five-year high for Shares Outstanding was $105.4 million in Q3 2025, with the low at $93140.0 in Q1 2023.
• Average Shares Outstanding over 5 years is $55.0 million, with a median of $87.5 million recorded in 2022.
• Year-over-year, Shares Outstanding jumped 109663.75% in 2022 and slumped 99.9% in 2024.
• Tracing SRPT's Shares Outstanding over 5 years: stood at $88.0 million in 2022, then grew by 6.57% to $93.7 million in 2023, then tumbled by 99.9% to $96900.0 in 2024, then soared by 108222.21% to $105.0 million in 2025, then slumped by 99.9% to $106227.0 in 2026.
• The last three Shares Outstanding figures came in at $106227.0 (Q1 2026), $105.0 million (Q4 2025), and $105.4 million (Q3 2025), per Business Quant data.

Peer Comparison